Ahammune Biosciences Secures $5M for Vitiligo Trials
Ahammune Biosciences raises $5M led by pi Ventures for Phase II trials, expanding R&D for skin disease treatments.
- Latest
- Trending
Ahammune Biosciences raises $5M led by pi Ventures for Phase II trials, expanding R&D for skin disease treatments.
AI empowers both scammers and defenders in data security, affecting banking, health, and more. Learn ways to safeguard your info.
Senators propose AI Civil Rights Act to prevent bias in AI, ensuring transparency and human decision-making options.
Ethereum ETFs see record outflows as Grayscale leads. Despite challenges, ETH price shows resilience above neutral RSI.
Webster Bank awards $100K grants to empower youth via Finance Labs, aiding financial literacy in low-income areas.
Explore the latest price forecasts for Toncoin with actionable insights for the next 48 hours, week, and month.
Amazon's Just Walk Out uses AI for precise shopping, offering checkout-free experiences in diverse global locations.
Microsoft removes 730,000 apps, enhances security with new measures to protect cloud infrastructure from cyber threats.
Bitcoin hits $63,703 amid Fed rate cut, boosting crypto. Ethereum, BNB, Solana also see gains as markets react.
Microsoft emphasizes cybersecurity with new hires and 34,000 engineers dedicated to security efforts.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.